A human-health risk assessment for West Nile virus and insecticides used in mosquito management
2006
West Nile Virus Risk Assessment
publication
Author Information
Author(s): Robert K.D. Peterson, Paula A. Macedo, Ryan S. Davis
Primary Institution: Montana State University
Hypothesis
What are the residential human risks from exposure to West Nile virus and mosquito adulticides?
Conclusion
The study reveals the magnitude of risk from West Nile virus and mosquito adulticides but does not conduct a risk-benefit assessment.
Supporting Evidence
- The study is an initial step in a multiyear analysis of risk issues related to vectorborne diseases.
- The authors clarify that their assessment does not indicate that health risks from adulticiding are offset by WNV reduction.
Takeaway
This study looks at how dangerous West Nile virus and mosquito sprays are to people, but it doesn't compare the risks and benefits.
Methodology
Screening-level risk assessment examining human risks from West Nile virus and mosquito adulticides.
Limitations
The study is a screening-level assessment and does not refine the risks or conduct a risk-benefit analysis.
Want to read the original?
Access the complete publication on the publisher's website